Evidence map›Paper›PMID 32437414›Full record

ArticlePloS one2020

Variants in IL23R-C1orf141 and ADO-ZNF365-EGR2 are associated with susceptibility to Vogt-Koyanagi-Harada disease in Japanese population.

Takuto Sakono, Akira Meguro, Masaki Takeuchi, Takahiro Yamane, Takeshi Teshigawara, Nobuyoshi Kitaichi, Yukihiro Horie, Kenichi Namba, Shigeaki Ohno, Kumiko Nakao and 15 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Immunometabolic regulation and tissue-resident immunity in autoimmune uveitis: from genetic susceptibility to the gut-spleen-eye axis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  2. Article
  3. Article
  4. Transcription factor EGR2 alleviates autoimmune uveitis via activation of GDF15 to modulate the retinal microglial phenotype.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. Article
  6. Article
  7. Progress in the genetics of uveitis.Genes and immunity · 2022
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 11 institutions in 1 country.

Takuto SakonoDepartment of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
Akira MeguroDepartment of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.ORCID 0000-0002-9797-0948
Masaki TakeuchiDepartment of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
Takahiro YamaneDepartment of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
Takeshi TeshigawaraDepartment of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.ORCID 0000-0001-8264-101X
Nobuyoshi KitaichiDepartment of Ophthalmology, Health Sciences University of Hokkaido, Hokkaido, Japan.
Yukihiro HorieDepartment of Ophthalmology, Health Sciences University of Hokkaido, Hokkaido, Japan.
Kenichi NambaDepartment of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Hokkaido, Japan.
Shigeaki OhnoDepartment of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Hokkaido, Japan.
Kumiko NakaoDepartment of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Taiji SakamotoDepartment of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Tsutomu SakaiDepartment of Ophthalmology, Jikei University School of Medicine, Tokyo, Japan.
Tadashi NakanoDepartment of Ophthalmology, Jikei University School of Medicine, Tokyo, Japan.
Hiroshi KeinoDepartment of Ophthalmology, Kyorin University School of Medicine, Tokyo, Japan.
Annabelle A OkadaDepartment of Ophthalmology, Kyorin University School of Medicine, Tokyo, Japan.
Atsunobu TakedaDepartment of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Takako ItoDepartment of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Hisashi MashimoDepartment of Ophthalmology, Japan Community Health care Organization Osaka Hospital, Osaka, Japan.
Nobuyuki OhguroDepartment of Ophthalmology, Japan Community Health care Organization Osaka Hospital, Osaka, Japan.
Shinichirou OonoDepartment of Ophthalmology, Saga University Faculty of Medicine, Saga, Japan.
Hiroshi EnaidaDepartment of Ophthalmology, Saga University Faculty of Medicine, Saga, Japan.
Satoshi OkinamiDepartment of Ophthalmology, Saga University Faculty of Medicine, Saga, Japan.
Nobuyuki HoritaDepartment of Pulmonology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
Masao OtaDepartment of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
Nobuhisa MizukiDepartment of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
Yokohama City University · JPSaga University · JPHealth Sciences University of Hokkaido · JPHokkaido University · JPJikei University School of Medicine · JPKagoshima University · JPKyorin University · JPKyushu University · JPOsaka Hospital · JPMinamiaoyama Eye Clinic · JPShinshu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vogt-Koyanagi-Harada (VKH) disease is a systemic inflammatory disorder that affects pigment cell-containing organs such as the eye (e.g., chronic and/or recurrent granulomatous panuveitis). While the exact etiology and pathogenic mechanism of VKH disease are unclear, HLA-DR4 alleles have been documented to be strongly associated with VKH disease in various ethnic groups. Recently, a genome-wide association study (GWAS) found two new genetic risk factors (IL23R-C1orf141 and ADO-ZNF365-EGR2) in a non-HLA region from a Han Chinese population. In this study, we replicated these GWAS findings in a Japanese population. A total of 1,643 Japanese samples (380 cases with VKH disease and 1,263 healthy controls) were recruited. We assessed four single nucleotide polymorphisms (SNPs) shown in previous GWAS: rs78377598 and rs117633859 in IL23R-C1orf141, and rs442309 and rs224058 in ADO-ZNF365-EGR2. A significant allelic association with VKH disease was observed for all of the four SNPs (rs78377598: pc = 0.0057; rs117633859: pc = 0.0017; rs442309: pc = 0.021; rs224058: pc = 0.035). In genotypic association analysis, the minor alleles of IL23R-C1orf141 rs78377598 and rs117633859 had the strongest association with disease susceptibility under the additive model (pc = 0.0075 and pc = 0.0026, respectively). The minor alleles of ADO-ZNF365-EGR2 rs442309 and rs224058 were most strongly associated with disease susceptibility under the dominant model (pc = 0.00099 and pc = 0.0023, respectively). The meta-analysis of the current and previous studies found that all of the four SNPs exhibited a significantly strong association with VKH disease (meta-p < 0.00001: rs78377598, meta-odds ratio (OR) = 1.69; rs1176338, meta-OR = 1.82; rs442309, meta-OR = 1.34; rs224058, meta-OR = 1.33). In summary, our study replicated significant associations with VKH disease susceptibility reported in a previous GWAS. Thus, the IL23R-C1orf141 and ADO-ZNF365-EGR2 loci may play important roles in the development of VKH disease through genetic polymorphisms.

Indexed as

Genetic Predisposition to DiseasePolymorphism, Single NucleotideAdultAllelesAsian PeopleCarotenoidsCase-Control StudiesDNA-Binding ProteinsEarly Growth Response Protein 2FemaleGene FrequencyGenome-Wide Association StudyHLA-DR4 AntigenHumansJapanMalebeta-apocarotenoid-14',13'-dioxygenaseCarotenoidsDNA-Binding ProteinsEarly Growth Response Protein 2EGR2 protein, humanHLA-DR4 AntigenIL23R protein, humanOxygenasesReceptors, InterleukinTranscription FactorsZNF365 protein, human

Identifiers

PMID32437414
PMCPMC7241744
OpenAlexW3028483605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.